Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer Disease. Cold Spring Harb Perspect Med. 2011;1:a006189–006189. https://doi.org/10.1101/cshperspect.a006189.
Article CAS PubMed PubMed Central Google Scholar
Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Sci (80-). 1992;256:184–5. https://doi.org/10.1126/science.1566067.
Long JM, Holtzman DM. Alzheimer Disease: an update on pathobiology and treatment strategies. Cell. 2019;179:312–39. https://doi.org/10.1016/j.cell.2019.09.001.
Article CAS PubMed PubMed Central Google Scholar
Uddin MS, Hasana S, Hossain MF, Islam MS, Behl T, Perveen A, Hafeez A, Ashraf GM. Molecular Genetics of early- and late-onset Alzheimer’s Disease. Curr Gene Ther. 2020;21:43–52. https://doi.org/10.2174/1566523220666201123112822.
Aisen PS, Cummings J, Jack CR, Morris JC, Sperling R, Frölich L, Jones RW, Dowsett SA, Matthews BR, Raskin J, Scheltens P, Dubois B. On the path to 2025: understanding the Alzheimer’s disease continuum. Alzheimers Res Ther. 2017;9:60. https://doi.org/10.1186/s13195-017-0283-5.
Article CAS PubMed PubMed Central Google Scholar
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, Cooper C, Fox N, Gitlin LN, Howard R, Kales HC, Larson EB, Ritchie K, Rockwood K, Sampson EL, et al. Dementia prevention, intervention, and care. Lancet. 2017;390:2673–734. https://doi.org/10.1016/S0140-6736(17)31363-6.
Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, Culliford D, Perry VH. Systemic inflammation and disease progression in alzheimer disease. Neurology. 2009;73:768–74. https://doi.org/10.1212/WNL.0b013e3181b6bb95.
Article CAS PubMed PubMed Central Google Scholar
Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015;16:358–72. https://doi.org/10.1038/nrn3880.
Article CAS PubMed Google Scholar
Huang J, Su B, Karhunen V, Gill D, Zuber V, Ahola-Olli A, Palaniswamy S, Auvinen J, Herzig KH, Keinänen-Kiukaanniemi S, Salmi M, Jalkanen S, Lehtimäki T, Salomaa V, Raitakari OT, Matthews PM, Elliott P, Tsilidis KK, Jarvelin MR, et al. Inflammatory diseases, inflammatory biomarkers, and Alzheimer Disease: an observational analysis and mendelian randomization. Neurology. 2023;100:568–81. https://doi.org/10.1212/WNL.0000000000201489.
Walker KA, Le Page LM, Terrando N, Duggan MR, Heneka MT, Bettcher BM. The role of peripheral inflammatory insults in Alzheimer’s disease: a review and research roadmap. Mol Neurodegener. 2023;18:37. https://doi.org/10.1186/s13024-023-00627-2.
Article CAS PubMed PubMed Central Google Scholar
Lopez-Rodriguez AB, Hennessy E, Murray CL, Nazmi A, Delaney HJ, Healy D, Fagan SG, Rooney M, Stewart E, Lewis A, de Barra N, Scarry P, Riggs‐Miller L, Boche D, Cunningham MO, Cunningham C. Acute systemic inflammation exacerbates neuroinflammation in Alzheimer’s disease: IL‐1β drives amplified responses in primed astrocytes and neuronal network dysfunction. Alzheimer’s Dement. 2021;17:1735–55. https://doi.org/10.1002/alz.12341.
Carter SF, Herholz K, Rosa-Neto P, Pellerin L, Nordberg A, Zimmer ER. Astrocyte biomarkers in Alzheimer’s Disease. Trends Mol Med. 2019;25:77–95. https://doi.org/10.1016/j.molmed.2018.11.006.
Article CAS PubMed Google Scholar
Pereira JB, Janelidze S, Smith R, Mattsson-Carlgren N, Palmqvist S, Teunissen CE, Zetterberg H, Stomrud E, Ashton NJ, Blennow K, Hansson O. Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease. Brain. 2021;144:3505–16. https://doi.org/10.1093/brain/awab223.
Article PubMed PubMed Central Google Scholar
Wang D, Zhang X, Du H. Inflammatory bowel disease: a potential pathogenic factor of Alzheimer’s disease. Prog Neuro-Psychopharmacology Biol Psychiatry. 2022;119:110610. https://doi.org/10.1016/j.pnpbp.2022.110610.
Kim JS, Chen M-H, Wang HE, Lu C-L, Wang Y-P, Zhang B. Inflammatory bowel disease and neurodegenerative diseases. Gut Liver. 2023;17:495–504. https://doi.org/10.5009/gnl220523.
Article CAS PubMed PubMed Central Google Scholar
Zhang B, Wang HE, Bai Y-M, Tsai S-J, Su T-P, Chen T-J, Wang Y-P, Chen M-H. Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study. Gut. 2021;70:85–91. https://doi.org/10.1136/gutjnl-2020-320789.
Aggarwal M, Alkhayyat M, Abou Saleh M, Sarmini MT, Singh A, Garg R, Garg P, Mansoor E, Padival R, Cohen BL. Alzheimer Disease occurs more frequently in patients with inflammatory bowel disease. J Clin Gastroenterol. 2023;57:501–7. https://doi.org/10.1097/MCG.0000000000001714.
Article CAS PubMed Google Scholar
Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in Gut-Brain communication. Front Endocrinol (Lausanne). 2020;11. https://doi.org/10.3389/fendo.2020.00025.
Webster SJ, Bachstetter AD, Nelson PT, Schmitt FA, Van Eldik LJ. Using mice to model Alzheimer’s dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet. 2014;5. https://doi.org/10.3389/fgene.2014.00088.
Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Sci (80-). 1996;274:99–102. https://doi.org/10.1126/science.274.5284.99.
Bábíčková J, Tóthová Ľ, Lengyelová E, Bartoňová A, Hodosy J, Gardlík R, Celec P. Sex differences in experimentally Induced Colitis in mice: a role for Estrogens. Inflammation. 2015;38:1996–2006. https://doi.org/10.1007/s10753-015-0180-7.
Article CAS PubMed Google Scholar
Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran Sulfate Sodium (DSS)‐Induced Colitis in mice. Curr Protoc Immunol. 2014;104. https://doi.org/10.1002/0471142735.im1525s104.
De Fazio L, Cavazza E, Spisni E, Strillacci A, Centanni M, Candela M, Praticò C, Campieri M, Ricci C, Valerii MC. Longitudinal analysis of inflammation and microbiota dynamics in a model of mild chronic dextran sulfate sodium-induced colitis in mice. World J Gastroenterol. 2014;20:2051–61. https://doi.org/10.3748/wjg.v20.i8.2051.
Article CAS PubMed PubMed Central Google Scholar
Niccolai E, Baldi S, Ricci F, Russo E, Nannini G, Menicatti M, Poli G, Taddei A, Bartolucci G, Calabrò AS, Stingo FC, Amedei A. Evaluation and comparison of short chain fatty acids composition in gut diseases. World J Gastroenterol. 2019;25:5543–58. https://doi.org/10.3748/wjg.v25.i36.5543.
Article CAS PubMed PubMed Central Google Scholar
Karstens L, Asquith M, Davin S, Fair D, Gregory WT, Wolfe AJ, Braun J, McWeeney S. Controlling for contaminants in Low-Biomass 16S rRNA gene sequencing experiments. MSystems. 2019;4. https://doi.org/10.1128/mSystems.00290-19.
Glassing A, Dowd SE, Galandiuk S, Davis B, Chiodini RJ. Inherent bacterial DNA contamination of extraction and sequencing reagents may affect interpretation of microbiota in low bacterial biomass samples. Gut Pathog. 2016;8:24. https://doi.org/10.1186/s13099-016-0103-7.
Article CAS PubMed PubMed Central Google Scholar
Tordoff MG. Taste Solution Preferences of C57BL/6J and 129X1/SvJ Mice: Influence of Age, Sex, and Diet. Chem Senses. 2007;32:655–71. https://doi.org/10.1093/chemse/bjm034.
Article CAS PubMed Google Scholar
Gil-Bea FJ, Aisa B, Schliebs R, Ramírez MJ. Increase of locomotor activity underlying the behavioral disinhibition in Tg2576 mice. Behav Neurosci. 2007;121:340–4. https://doi.org/10.1037/0735-7044.121.2.340.
Kosel F, Pelley JMS, Franklin TB. Behavioural and psychological symptoms of dementia in mouse models of Alzheimer’s disease-related pathology. Neurosci Biobehav Rev. 2020;112:634–47. https://doi.org/10.1016/j.neubiorev.2020.02.012.
Article CAS PubMed Google Scholar
Higaki A, Mogi M, Iwanami J, Min L-J, Bai H-Y, Shan B-S, Kan-no H, Ikeda S, Higaki J, Horiuchi M. Recognition of early stage thigmotaxis in Morris water maze test with convolutional neural network. PLoS ONE. 2018;13:e0197003. https://doi.org/10.1371/journal.pone.0197003.
Article CAS PubMed PubMed Central Google Scholar
Jurga AM, Paleczna M, Kuter KZ. Overview of General and discriminating markers of Differential Microglia phenotypes. Front Cell Neurosci. 2020;14. https://doi.org/10.3389/fncel.2020.00198.
Chen Y, Colonna M. Microglia in Alzheimer’s disease at single-cell level. Are there common patterns in humans and mice? J Exp Med. 2021;218. https://doi.org/10.1084/jem.20202717.
Joly-Amado A, Hunter J, Quadri Z, Zamudio F, Rocha-Rangel PV, Chan D, Kesarwani A, Nash K, Lee DC, Morgan D, Gordon MN, Selenica MLB. CCL2 overexpression in the Brain promotes glial activation and accelerates Tau Pathology in a mouse model of Tauopathy. Front Immunol. 2020;11. https://doi.org/10.3389/fimmu.2020.00997.
Li T, Zhu J. Entanglement of CCR5 and Alzheimer’s Disease. Front Aging Neurosci. 2019;11. https://doi.org/10.3389/fnagi.2019.00209.
Fernández Zapata C, Giacomello G, Spruth EJ, Middeldorp J, Gallaccio G, Dehlinger A, Dames C, Leman JKH, van Dijk RE, Meisel A, Schlickeiser S, Kunkel D, Hol EM, Paul F, Parr MK, Priller J, Böttcher C. Differential compartmentalization of myeloid cell phenotypes and responses towards the CNS in Alzheimer’s disease. Nat Commun. 2022;13:7210. https://doi.org/10.1038/s41467-022-34719-2.
Article CAS PubMed PubMed Central Google Scholar
Ager RR, Fonseca MI, Chu S, Sanderson SD, Taylor SM, Woodruff TM, Tenner AJ. Microglial C5aR (CD88) expression correlates with amyloid-β deposition in murine models of Alzheimer’s disease. J Neurochem. 2010;113:389–401. https://doi.org/10.1111/j.1471-4159.2010.06595.x.
Article CAS PubMed PubMed Central Google Scholar
Francistiová L, Bianchi C, Di Lauro C, Sebastián-Serrano Á, de Diego-García L, Kobolák J, Dinnyés A, Díaz-Hernández M. The role of P2X7 receptor in Alzheimer’s Disease. Front Mol Neurosci. 2020;13.
留言 (0)